724 related articles for article (PubMed ID: 11399091)
1. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
3. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
[TBL] [Abstract][Full Text] [Related]
4. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
[TBL] [Abstract][Full Text] [Related]
5. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
6. The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes.
Kampranis SC; Howells AJ; Maxwell A
J Mol Biol; 1999 Oct; 293(3):733-44. PubMed ID: 10543963
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions.
Sissi C; Perdonà E; Domenici E; Feriani A; Howells AJ; Maxwell A; Palumbo M
J Mol Biol; 2001 Aug; 311(1):195-203. PubMed ID: 11469868
[TBL] [Abstract][Full Text] [Related]
8. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
[TBL] [Abstract][Full Text] [Related]
9. Investigating the role of the latch in the positive supercoiling mechanism of reverse gyrase.
Rodríguez AC
Biochemistry; 2003 May; 42(20):5993-6004. PubMed ID: 12755601
[TBL] [Abstract][Full Text] [Related]
10. Histone-like protein HU and bacterial DNA topology: suppression of an HU deficiency by gyrase mutations.
Malik M; Bensaid A; Rouviere-Yaniv J; Drlica K
J Mol Biol; 1996 Feb; 256(1):66-76. PubMed ID: 8609614
[TBL] [Abstract][Full Text] [Related]
11. The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex.
Wentzell LM; Maxwell A
J Mol Biol; 2000 Dec; 304(5):779-91. PubMed ID: 11124026
[TBL] [Abstract][Full Text] [Related]
12. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
13. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
[TBL] [Abstract][Full Text] [Related]
14. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Neumann S; Quiñones A
J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
[TBL] [Abstract][Full Text] [Related]
15. Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.
Aleixandre V; Herrera G; Urios A; Blanco M
Antimicrob Agents Chemother; 1991 Jan; 35(1):20-3. PubMed ID: 1849710
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
[TBL] [Abstract][Full Text] [Related]
17. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.
Critchlow SE; Maxwell A
Biochemistry; 1996 Jun; 35(23):7387-93. PubMed ID: 8652515
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
Wu LC; Shahied SI
Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
[TBL] [Abstract][Full Text] [Related]
19. Adenosine 5'-O-(3-thio)triphosphate (ATPgammaS) promotes positive supercoiling of DNA by T. maritima reverse gyrase.
Jungblut SP; Klostermeier D
J Mol Biol; 2007 Aug; 371(1):197-209. PubMed ID: 17560602
[TBL] [Abstract][Full Text] [Related]
20. Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase.
Smith CV; Maxwell A
Biochemistry; 1998 Jul; 37(27):9658-67. PubMed ID: 9657678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
